Amneal Q2 Earnings Tops Estimates; Backs FY21 Guidance

Amneal Pharmaceuticals Inc (NYSE:AMRX) reports Q2 revenue of $535 million, an increase of 15% Y/Y, beating the consensus of $523.25…
  • Amneal Pharmaceuticals Inc (NYSE:AMRX) reports Q2 revenue of $535 million, an increase of 15% Y/Y, beating the consensus of $523.25 million.
  • Sales growth was driven by Generic product launches, specialty products Rytary & Unithroid, and overall volume growth within Generics and AvKARE segments.
  • The gross margin expanded from 31% a year ago to 39.7%, buoyed by the Generics segment.
  • Adjusted EPS almost doubled to $0.25, ahead of the consensus of $0.19.
  • Amneal held cash and equivalents of $283.15 million at the end of Q2.
  • Adjusted EBITDA was $151 million, an increase of 50% Y/Y reflective of net income growth. 
  • Outlook: Amneal maintains previously provided guidance for FY21 with sales of $2.1 billion – $2.2 billion (consensus $2.12 billion).
  • It expects adjusted EBITDA of $500 million – $540 million and adjusted EPS of $0.70 – $0.85 (consensus $0.82).
  • Price Action: AMRX shares closed at $4.87 on Friday.
Total
0
Shares
Related Posts
Read More

50 Facts And Figures About Elon Musk On His 50th Birthday

One of the world’s most well-known CEOs, Elon Reeve Musk was born June 28, 1971, in South Africa and is celebrating his 50th birthday in 2021. Known for his use of memes on social media including mentions of popular jokes involving 69 and 4/20, it might come as a surprise that with a birthday on June 28, Musk was born 69 days after 4/20.

AAPL